Foley & Lardner LLP announced today that Philippe Riesen has joined the firm’s Intellectual Property Department and Chemical, Biotechnology & Pharmaceutical Practice as a partner in the Tokyo office.
Riesen has been assisting Japanese companies with U.S. patent litigation and counseling for more than 25 years.
He is experienced in a wide range of intellectual property disciplines, including U.S. and multi-district litigation and dispute resolution; America Invents Act (AIA) post-grant proceedings before the Patent Trials and Appeal Board (PTAB) at the U.S. Patent and Trademark Office (USPTO); licensing strategy, drafting and negotiation; commercialization and technology transfer; product and invention due diligence and valuation; patent landscaping and monetization; patent portfolio management; patent prosecution; and regulatory advice and strategies..
“Philippe’s arrival expands our global patent bench in patent litigation and prosecution. Having his boots-on-the ground presence as an experienced litigator and registered U.S. patent attorney based in Tokyo will be an invaluable resource to our Japanese clients,” said Michele Simkin, chair of the firm’s Intellectual Property Department.
Riesen’s technical background is in biochemistry. With his prior experience working in-house at a major pharmaceutical company and litigating numerous Hatch-Waxman cases, he has a particular interest in the pharmaceutical and medical device industry, focusing on litigation, due diligence and life-cycle management. Riesen has also represented companies in intellectual property disputes covering a wide range of technologies ranging from chemicals and bio chemicals, biotechnology, polymers and plastics, to electronics and turbine technology.
“As our clients in Japan seek to enter new markets, they will benefit from Philippe’s knowledge of global intellectual property challenges and opportunities. His experience working with pharmaceutical companies will help expand Foley’s already prominent industry presence in the region,” said Etsuo Doi, managing partner of Foley’s Tokyo office.
Prior to joining Foley, Riesen was a partner at Hogan Lovells and also served as in-house counsel to a major Japanese pharmaceutical company.
Riesen has been assisting Japanese companies with U.S. patent litigation and counseling for more than 25 years.
He is experienced in a wide range of intellectual property disciplines, including U.S. and multi-district litigation and dispute resolution; America Invents Act (AIA) post-grant proceedings before the Patent Trials and Appeal Board (PTAB) at the U.S. Patent and Trademark Office (USPTO); licensing strategy, drafting and negotiation; commercialization and technology transfer; product and invention due diligence and valuation; patent landscaping and monetization; patent portfolio management; patent prosecution; and regulatory advice and strategies..
“Philippe’s arrival expands our global patent bench in patent litigation and prosecution. Having his boots-on-the ground presence as an experienced litigator and registered U.S. patent attorney based in Tokyo will be an invaluable resource to our Japanese clients,” said Michele Simkin, chair of the firm’s Intellectual Property Department.
Riesen’s technical background is in biochemistry. With his prior experience working in-house at a major pharmaceutical company and litigating numerous Hatch-Waxman cases, he has a particular interest in the pharmaceutical and medical device industry, focusing on litigation, due diligence and life-cycle management. Riesen has also represented companies in intellectual property disputes covering a wide range of technologies ranging from chemicals and bio chemicals, biotechnology, polymers and plastics, to electronics and turbine technology.
“As our clients in Japan seek to enter new markets, they will benefit from Philippe’s knowledge of global intellectual property challenges and opportunities. His experience working with pharmaceutical companies will help expand Foley’s already prominent industry presence in the region,” said Etsuo Doi, managing partner of Foley’s Tokyo office.
Prior to joining Foley, Riesen was a partner at Hogan Lovells and also served as in-house counsel to a major Japanese pharmaceutical company.
Related News
30 November 2023
Press Releases
Foley Represents Novacap in Investment in Harmony Healthcare IT
Foley & Lardner LLP served as legal advisor to Novacap, one of North America’s leading private equity firms, in its significant investment in Harmony Healthcare IT (HHIT), a health data management and platform solutions provider.
07 November 2023
Press Releases
Foley Represents Hilton Grand Vacations in Acquisition of Bluegreen Vacations
Foley & Lardner LLP served as lead timeshare counsel to Hilton Grand Vacations Inc. in its definitive agreement to acquire Bluegreen Vacations.
06 November 2023
Press Releases
Foley Expands Innovative Technology Sector and Government Enforcement Defense & Investigations Practice with Addition of Former Federal Prosecutor Joe Swanson
Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology capabilities and Government Enforcement Defense & Investigations Practice with the addition of partner Joe Swanson in Tampa.